CVS CVS Health

8-K Current Report
Filed: March 19, 2026
Consumer Discretionary
Retail-Drug Stores and Proprietary Stores

CVS Health (CVS) 8-K current report filed with SEC EDGAR on March 19, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 5.02: Departure/Election of Directors or Officers

AI Filing Analysis
8-K

Item 5.02 · Departure/Election of Directors or Officers

  • John E. Gallina, former CFO of Elevance Health (2016-2023), appointed to CVS Health Board effective March 19, 2026
  • Gallina named to Audit Committee, designated audit committee financial expert under SEC rules
+3 more insights

Get deeper insights on CVS Health

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.